PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 19 (1) , 1-8
Abstract
Background: Phosphoglucomutase (PGM), a key enzyme in the metabolism of glucose-1-phosphate and glucose-6-phosphate, has been found to be associated with proliferation, invasion, and metastasis of cancer. However, the expression and function of PGM5 in colorectal cancer (CRC) remains unknown.Methods: We tested PGM5 mRNA and protein expression levels in 79 CRC tissue and their matched adjacent tissue samples by qRT-PCR and immunohistochemistry, respectively. Overall survival (OS) was estimated with the Kaplan–Meier method and compared between groups with the log-rank test. We performed multivariable Cox regression analyses to identify factors associated with CRC risk. The cell proliferation, migration and invasion abilities of CRC cells were detected by using CCK-8, Transwell migration and invasion assays, respectively.Results: The PGM5 protein levels expression in CRC tissues were significantly lower than those in the adjacent tissues (t = 5.035,P < 0.001), and Kaplan–Meier analysis indicated that low PGM5 expression were significantly associated with poor overall survival (P = 0.0069). Univariate and multivariate analyses demonstrated that PGM5 was an independent risk factor for overall survival (hazard ratio = 0.3951,P = 0.014). PGM5 overexpression significantly inhibited the proliferation, invasion and migration abilities of CRC cells. On the contrary, knockdown of PGM5 promotes the invasion and migration of CRC cells.Conclusions: PMG5 regulates proliferation, invasion, and migration in the CRC and decreased PGM5 is associated with poor prognosis. Therefore, PGM5 is a promising biomarker in CRC and decreased PGM5 may predict poor overall survival in patients with CRC.Keywords
This publication has 20 references indexed in Scilit:
- Aciculin interacts with filamin C and Xin and is essential for myofibril assembly, remodeling and maintenanceJournal of Cell Science, 2014
- PGAMgnam Style: A Glycolytic Switch Controls BiosynthesisCancer Cell, 2012
- A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorderJournal of Affective Disorders, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Tumor microenvironment: a main actor in the metastasis processClinical & Experimental Metastasis, 2012
- A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinomaFunctional & Integrative Genomics, 2011
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cellsProteome Science, 2010
- A Novel Human Phosphoglucomutase (PGM5) Maps to the Centromeric Region of Chromosome 9Genomics, 1995